The New York state attorney general's office said 20 states have filed a civil lawsuit against Teva, Mylan, Mayne Pharma, Heritage Pharmaceuticals, Aurobindo Pharma and Citron Pharma, alleging the companies entered into illegal conspiracies that raised prices on two generic drugs, as reported by FOX Business.
The news follows the first charges laid by the US Justice Department stemming from a sweeping two-year antitrust probe into the generic-drug industry.
The lawsuit, filed in the US District Court for the District of Connecticut, describes Heritage as the "principal architect and ringleader" that helped organize a "wide-ranging series of conspiracies" to fix prices.
The complaint alleges that senior executives of the drug companies and their sales executives boosted the prices of the antibiotic doxycycline and the diabetes drug glyburide by fixing their prices or allocating markets.
"Companies that collude and fix prices for generic drugs in order to pad their profits must be held accountable for the very real harm they inflict on New Yorkers' ability to pay for life-saving medications," stated New York Attorney General Eric Schneiderman.
The lead state in the probe was Connecticut and the other states involved are Delaware, Florida, Hawaii, Idaho, Iowa, Kansas, Kentucky, Louisiana,
Maine, Maryland, Massachusetts, Minnesota, Nevada, New York, North Dakota, Ohio, Pennsylvania, Virginia and Washington.
To read more NewsPoints articles, click here.